🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.

Recruitingn/aAges 60 Years - anyAllCasa di Cura IGEA
NCT06701630 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The first aim of the observational study is the translation, cross-cultural adaptation and validation of functional and behavioral scales used in the diagnosis of neurodegenerative diseases, for which a formal version in Italian is not available at present. In particular, the study includes the following functional and behavioral scales: the Katz's index (Basic Activities of Daily Living, BADL), the Lawton and Brody's scale (Instrumental Activities of Daily Living, IADL), the Everyday Cognition questionnaire (E-Cog), the Neuropsychiatric Inventory Questionnaire (NPI-Q) for assessing the Behavioral and Psychological Symptoms of Dementia. Furthermore, a modified Italian version of the Functional Activities Questionnaire (FAQ), which integrates and updates the content of the original items (e.g., addressing the use of technologies, M-FAQ) will be used in the validation study. The second ai

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 60 years; * Availability of an informant/caregiver, able to judge their functional abilities. For neurologically unimpaired elderly: \- Normal performance on the Mini Mental State Examination (Folstein et al. 1975; Foderaro et al., 2022). For clinical groups: Conditions consistent with: * Subjective Cognitive Decline (Jessen et al., 2014) * Mild Cognitive Impairment (Winblad et al., 2004) * Mild Major Neurocognitive Disorder according (DSM-5-TR, APA, 2022). Exclusion Criteria: * Refusal or inability to sign informed consent; * For the clinical groups: other neurological or psychiatric conditions that may explain the presence of cognitive difficulties.
💊

What it tests

  • Not listed
📍

Where

1 site
Casa di Cura Igea
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy